首页> 美国卫生研究院文献>Journal of Translational Medicine >Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line
【2h】

Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line

机译:人神经胶质瘤细胞系中的磺化铝酞菁光动力处理诱导克隆细胞存活的非单调变化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPhotodynamic therapy (PDT) involves excitation of sensitizer molecules by visible light in the presence of molecular oxygen, thereby generating reactive oxygen species (ROS) through electron/energy transfer processes. The ROS, thus produced can cause damage to both the structure and the function of the cellular constituents resulting in cell death. Our preliminary investigations of dose-response relationships in a human glioma cell line (BMG-1) showed that disulphonated aluminum phthalocyanine (AlPcS2) photodynamically induced loss of cell survival in a concentration dependent manner up to 1 μM, further increases in AlPcS2concentration (>1 μM) were, however, observed to decrease the photodynamic toxicity. Considering the fact that for most photosensitizers only monotonic dose-response (survival) relationships have been reported, this result was unexpected. The present studies were, therefore, undertaken to further investigate the concentration dependent photodynamic effects of AlPcS2.
机译:背景技术光动力疗法(PDT)涉及在分子氧存在下通过可见光激发敏化剂分子,从而通过电子/能量转移过程产生活性氧物质(ROS)。如此产生的ROS可破坏细胞成分的结构和功能,导致细胞死亡。我们对人类神经胶质瘤细胞系(BMG-1)的剂量反应关系进行的初步研究表明,二磺化酞菁铝(AlPcS2)以高达1μM的浓度依赖性以光动力学方式诱导细胞存活率的丧失,AlPcS2浓度进一步升高(> 1然而,观察到μM)降低了光动力毒性。考虑到大多数光敏剂仅报告了单调剂量反应(生存)关系这一事实,这一结果是出乎意料的。因此,进行本研究以进一步研究AlPcS2的浓度依赖性光动力效应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号